Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
Stopped Accrual goal met
Conditions
- Immune and Microbial Reconstitution
- Systemic Viral Infection
- Acute-graft-versus-host Disease
- Chronic Graft-versus-host-disease
- Recurrent Malignancy
- Cytokine Release Syndrome
- Allogenic Related Donors
- Cell Therapy/Immunotherapy Patients
Interventions
- DIAGNOSTIC_TEST: Blood Sample
- DIAGNOSTIC_TEST: Stool Sample
- DIAGNOSTIC_TEST: Urine Sample
- DIAGNOSTIC_TEST: Bronchoalveolar Lavage (BAL) fluid
- DIAGNOSTIC_TEST: Gastrointestinal biopsy x 2-4
- DIAGNOSTIC_TEST: Skin biopsy
- DIAGNOSTIC_TEST: Skin, mouth, and/or ocular swab
- DIAGNOSTIC_TEST: Apheresis Product
- DIAGNOSTIC_TEST: Final cellular product
Sponsor
Masonic Cancer Center, University of Minnesota